MOTPOLY XR
NDC 73289-0064, lacosamide, capsule, extended release, from Aucta Pharmaceuticals, Inc..
- Product NDC
- 73289-0064
- Status
- Listed
- Labeler
- Aucta Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216185
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE150 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73289-0064-2 | 73289006402 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0064-2) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fb8235b4-4cd3-6f22-e053-6294a90a545cNADAC price for package 73289006402
GET /v1/drugs/nadac/73289006402
Use it
Look up 73289-0064 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0064 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73289-0064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.